Evaxion Biotech A/S (EVAX) Institutional Ownership → Things Are Not Normal in America – Here’s What to Do (From Stansberry Research) (Ad) Free EVAX Stock Alerts $3.84 -0.03 (-0.78%) (As of 10:55 AM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Evaxion Biotech A/S (NASDAQ:EVAX)CurrentInstitutional OwnershipPercentage11.04%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$3.41MNumber ofInstitutional Sellers(last 12 months)0 Get EVAX Insider Trade Alerts Want to know when executives and insiders are buying or selling Evaxion Biotech A/S stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data EVAX Institutional Buying and Selling by Quarter Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide Evaxion Biotech A/S Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2024LM Advisors LLC337,336$231K0.0%N/A8.898% 1/9/2024Beacon Capital Management LLC48,633$33K0.0%+606.8%0.173% 10/11/2023AE Wealth Management LLC48,633$41K0.0%N/A0.176% 5/12/2023 Moloney Securities Asset Management LLC36,000$41K0.0%N/A0.142% 2/14/2023Pura Vida Investments LLC16,842$30K0.0%N/A0.071% 11/17/2022Telemetry Investments L.L.C.29,000$76K0.1%-76.2%0.122% 11/16/2021Telemetry Investments L.L.C.30,743$296K0.4%-26.3%0.160% 11/12/2021Credit Suisse AG40,315$389K0.0%N/A0.210% 8/16/2021Maven Securities LTD235,606$1.76M0.1%+2.2%1.227% 8/16/2021Telemetry Investments L.L.C.41,729$315K0.4%-43.5%0.217% 5/18/2021Luminus Management LLC194,929$1.15M0.2%N/A1.015% 5/18/2021Alyeska Investment Group L.P.86,726$512K0.0%N/A0.452% 5/13/2021Kepos Capital LP37,098$219K0.0%N/A0.193% 5/12/2021Granite Point Capital Management L.P.224,601$1.33M0.0%N/A1.170% (Data available from 1/1/2016 forward) EVAX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EVAX shares? During the previous two years, the following institutional investors and hedge funds held shares of Evaxion Biotech A/S shares: LM Advisors LLC ($231K), Telemetry Investments L.L.C. ($76K), AE Wealth Management LLC ($41K), Moloney Securities Asset Management LLC ($41K), and Beacon Capital Management LLC ($33K), Pura Vida Investments LLC ($30K).Learn more on EVAX's institutional investors. What percentage of Evaxion Biotech A/S stock is owned by institutional investors? 11.04% of Evaxion Biotech A/S stock is owned by institutional investors. Learn more on EVAX's institutional investor holdings. Which institutional investors have been buying Evaxion Biotech A/S stock? The following institutional investors have purchased Evaxion Biotech A/S stock in the last 24 months: LM Advisors LLC ($337.34K), AE Wealth Management LLC ($48.63K), Beacon Capital Management LLC ($41.75K), Moloney Securities Asset Management LLC ($36K), and Pura Vida Investments LLC ($16.84K). How much institutional buying is happening at Evaxion Biotech A/S? Institutional investors have bought a total of 480,563 shares in the last 24 months. This purchase volume represents approximately $3.71M in transactions. Which Evaxion Biotech A/S major shareholders have been selling company stock? The following institutional investors have sold Evaxion Biotech A/S stock in the last 24 months: Telemetry Investments L.L.C. ($93K). How much institutional selling is happening at Evaxion Biotech A/S? Institutional investors have sold a total of 93,000 shares in the last 24 months. This volume of shares sold represents approximately $2.45M in transactions. Related Companies: CASI Pharmaceuticals Institutional Ownership LianBio Institutional Ownership Ocuphire Pharma Institutional Ownership Benitec Biopharma Institutional Ownership TherapeuticsMD Institutional Ownership Flora Growth Institutional Ownership Cue Health Institutional Ownership ZIVO Bioscience Institutional Ownership Ekso Bionics Institutional Ownership DermTech Institutional Ownership This page (NASDAQ:EVAX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe Exchange348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evaxion Biotech A/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
